SPBC354.10 Antibody

What is SPBC354.10 and why is it significant in fission yeast research?

SPBC354.10 is a gene in Schizosaccharomyces pombe that follows the systematic naming convention used for fission yeast genes. Based on the organization of the S. pombe genome, SPBC354.10 would be located on chromosome 2, as indicated by the "BC" designation in its name. The protein product may be involved in essential cellular processes, given that many genes in the SPBC354 locus have been characterized as essential for viability in genome-wide studies . The antibody targeting this protein is particularly valuable for investigating protein expression, localization, and function in molecular pathways within fission yeast cells.

What types of SPBC354.10 antibodies are available for research applications?

Researchers typically have access to several types of SPBC354.10 antibodies:

• Polyclonal antibodies: Generated by immunizing animals (typically rabbits) with purified SPBC354.10 protein or specific peptides derived from its sequence

• Monoclonal antibodies: Produced from hybridoma cell lines that secrete antibodies targeting specific epitopes of SPBC354.10

• Tagged antibodies: These recognize epitope tags (such as FLAG, HA, or His) that may be fused to SPBC354.10 in engineered strains, similar to the tagging approaches used for other S. pombe proteins in chromatin studies

The choice between these depends on the specific application, with monoclonal antibodies offering higher specificity and polyclonal antibodies generally providing stronger signals due to recognition of multiple epitopes.

How can I validate the specificity of an SPBC354.10 antibody?

Validation of SPBC354.10 antibody specificity should include:

• Western blot analysis using wild-type S. pombe extracts compared with extracts from SPBC354.10 deletion strains (if viable) or strains with reduced expression

• Immunoprecipitation followed by mass spectrometry to confirm that the pulled-down protein is indeed SPBC354.10

• Peptide competition assays where pre-incubation of the antibody with the immunizing peptide should eliminate specific signals

• Cross-reactivity testing with closely related proteins in S. pombe

• Testing the antibody in strains expressing tagged versions of SPBC354.10 (such as SPBC354.10-TAP or FLAG-SPBC354.10) to confirm co-localization of signals

What are the recommended fixation and permeabilization methods for immunofluorescence with SPBC354.10 antibody?

For optimal immunofluorescence results with SPBC354.10 antibody in S. pombe cells:

• Fixation: Use 3-4% formaldehyde for 30 minutes at room temperature. For proteins associated with chromatin structures, combining formaldehyde with a small percentage of glutaraldehyde (0.1-0.2%) may improve preservation of nuclear structures

• Permeabilization: Treat fixed cells with 1.2M sorbitol containing 0.5-1% Triton X-100, or use enzymatic digestion with Zymolyase (1mg/ml) for 30-60 minutes at 37°C

• Blocking: Block with 5% BSA or 5% normal serum in PBS for at least 30 minutes to reduce non-specific binding

• Primary antibody incubation: Incubate with SPBC354.10 antibody at 1:100 to 1:500 dilution overnight at 4°C

• Washing: Perform at least 3-5 washes with PBS containing 0.1% Tween-20

This protocol should be optimized based on the specific antibody characteristics and the subcellular localization of SPBC354.10.

How should I design chromatin immunoprecipitation (ChIP) experiments using SPBC354.10 antibody?

For effective ChIP experiments with SPBC354.10 antibody:

• Crosslinking: Treat S. pombe cells with 1% formaldehyde for 15-20 minutes at room temperature

• Cell lysis: Use glass bead disruption in lysis buffer containing protease inhibitors

• Chromatin fragmentation: Sonicate to generate DNA fragments of 200-500bp

• Immunoprecipitation: Incubate chromatin with SPBC354.10 antibody (2-5μg) bound to protein A/G beads overnight at 4°C

• Controls: Include non-specific IgG antibody control and input chromatin control

• Washing: Use increasingly stringent wash buffers to reduce non-specific binding

• Elution and reverse crosslinking: Elute protein-DNA complexes and reverse crosslinks at 65°C overnight

• DNA purification and analysis: Purify DNA and analyze by qPCR or sequencing

This approach is similar to ChIP protocols used for other chromatin-associated factors in S. pombe, such as those designed for Png1p and Mst1 studies .

What is the optimal protein extraction method for detecting SPBC354.10 by Western blot?

For efficient extraction and detection of SPBC354.10:

• Harvesting: Collect cells during logarithmic growth phase (OD600 of 0.5-0.8)

• Cell lysis options:

  • TCA precipitation: Add 20% TCA to cell pellet, vortex with glass beads, and precipitate proteins

  • Native extraction: Use HB buffer (25mM MOPS pH 7.2, 15mM MgCl2, 15mM EGTA, 60mM β-glycerophosphate, 1mM DTT, 0.1mM sodium vanadate, 1% Triton X-100) with protease inhibitors

• Sample preparation: Heat samples at 95°C for 5 minutes in SDS-PAGE loading buffer

• Gel selection: Use 10-12% polyacrylamide gels for optimal separation

• Transfer: Transfer to PVDF membrane at 100V for 1 hour or 30V overnight

• Blocking: Block with 5% non-fat milk in TBST for 1 hour

• Primary antibody: Incubate with SPBC354.10 antibody (1:1000-1:5000) overnight at 4°C

• Detection: Use appropriate secondary antibody and ECL detection system

This protocol is designed to preserve protein integrity while maximizing extraction efficiency, similar to methods used for other fission yeast proteins like Rbm10 .

How can I use the SPBC354.10 antibody to study protein-protein interactions?

To investigate SPBC354.10 protein interactions:

• Co-immunoprecipitation (Co-IP):

  • Prepare native protein extracts using gentle lysis buffers

  • Incubate with SPBC354.10 antibody coupled to protein A/G beads

  • Wash with buffer containing 0.1-0.2% NP-40 or Triton X-100

  • Analyze co-precipitated proteins by Western blot or mass spectrometry

• Proximity-dependent labeling:

  • Create fusion proteins with BioID or APEX2 tags

  • Induce biotinylation of proximal proteins

  • Purify biotinylated proteins using streptavidin beads

  • Identify interaction partners by mass spectrometry

• Yeast two-hybrid screening:

  • Clone SPBC354.10 as bait in appropriate vectors

  • Screen against S. pombe cDNA library

  • Validate potential interactions using the above methods

These approaches have been successfully applied to identify protein interactions in S. pombe, as demonstrated in studies of Rbm10 where tandem affinity purification (TAP) revealed associations with the Clr6 complex .

Why might I experience weak or no signal when using SPBC354.10 antibody in Western blots?

Several factors could contribute to weak SPBC354.10 detection:

• Low protein expression: SPBC354.10 may be expressed at very low levels under standard conditions, similar to other fission yeast proteins like FLAG-HA-Rbm10 that show extremely low endogenous expression

• Epitope masking: The antibody's epitope may be obscured due to:

  • Protein folding in native conditions

  • Post-translational modifications

  • Protein-protein interactions

  • Try denaturing conditions or different extraction buffers

• Antibody quality issues:

  • Storage conditions may have compromised activity

  • Batch variation in commercial antibodies

  • Try different antibody concentrations (1:100 to 1:5000)

• Technical factors:

  • Inefficient protein transfer to membrane

  • Excessive washing removing antibody

  • Incompatible blocking agents

  • Try optimizing each step independently

• Solution approaches:

  • Use tagged versions of SPBC354.10 and detect with anti-tag antibodies

  • Concentrate proteins using immunoprecipitation before Western blot

  • Try alternative extraction methods designed for low-abundance proteins

How can I reduce background and non-specific binding when using SPBC354.10 antibody?

To improve signal-to-noise ratio:

• Blocking optimization:

  • Test different blocking agents (BSA, milk, commercial blockers)

  • Increase blocking time to 2-3 hours at room temperature

  • Add 0.1-0.2% Tween-20 to blocking buffer

• Antibody dilution and incubation:

  • Prepare antibody in fresh blocking buffer

  • Incubate longer at lower temperature (overnight at 4°C)

  • Pre-adsorb antibody with S. pombe extract from SPBC354.10 deletion strain

• Washing stringency:

  • Increase number of washes (5-6 times, 10 minutes each)

  • Add higher concentrations of detergent (0.1-0.5% Tween-20)

  • Include salt (up to 500mM NaCl) in wash buffers

• Cross-reactivity reduction:

  • Use peptide-purified antibodies

  • Include competing peptides to block non-specific interactions

  • Apply two-step detection methods for increased specificity

• Sample preparation:

  • Further purify protein extracts through additional centrifugation steps

  • Use fractionation to enrich for compartments where SPBC354.10 is expected

What controls should I include when using SPBC354.10 antibody in my experiments?

Essential controls include:

• Negative controls:

  • SPBC354.10 deletion strain (if viable) or knockdown samples

  • Non-specific IgG of same species as primary antibody

  • Primary antibody omission

  • Peptide competition (pre-incubation with immunizing peptide)

• Positive controls:

  • Recombinant SPBC354.10 protein or peptide

  • Strains overexpressing SPBC354.10

  • Tagged SPBC354.10 detected with alternative antibodies

• Loading and technical controls:

  • Housekeeping proteins (tubulin, actin) for Western blots

  • Total histone H3 for ChIP experiments

  • Input samples for immunoprecipitation

  • DAPI staining for immunofluorescence

• Validation controls:

  • Alternative antibody targeting different epitope of SPBC354.10

  • Different experimental approaches confirming the same result

  • Genetic complementation showing restoration of lost signals

These controls establish specificity and reliability, particularly important for studying potentially low-abundance proteins like SPBC354.10 .

How can SPBC354.10 antibody be used to investigate chromatin association and transcriptional regulation?

For studying SPBC354.10's role in chromatin processes:

• Chromatin Immunoprecipitation sequencing (ChIP-seq):

  • Perform ChIP with SPBC354.10 antibody as described in section 2.1

  • Prepare libraries from immunoprecipitated DNA

  • Sequence and map to S. pombe genome

  • Identify genome-wide binding sites and motifs

  • Compare binding profiles with known transcription factors and chromatin modifiers

• ChIP-qPCR for targeted analysis:

  • Design primers for specific genomic regions of interest

  • Quantify SPBC354.10 enrichment at these loci

  • Compare enrichment across different conditions or mutant backgrounds

  • This approach has been effective for studying factors like PAF and Prf1

• Sequential ChIP (re-ChIP):

  • First IP with SPBC354.10 antibody

  • Elute complexes and perform second IP with antibodies against histone modifications or other proteins

  • Determine co-occupancy at specific genomic regions

• Integration with transcriptomic data:

  • Correlate SPBC354.10 binding with gene expression changes

  • Analyze effects of SPBC354.10 deletion/mutation on transcriptome

  • Identify genes directly regulated by SPBC354.10

These approaches can reveal whether SPBC354.10 functions similarly to other characterized chromatin factors in S. pombe .

How does cell cycle stage affect SPBC354.10 expression and localization?

To investigate cell cycle-dependent dynamics:

• Synchronized culture analysis:

  • Synchronize S. pombe cells using:

    • Nitrogen starvation and release

    • Hydroxyurea block and release

    • cdc25-22 temperature-sensitive mutant

  • Collect samples at different time points post-synchronization

  • Analyze SPBC354.10 levels by Western blot

  • Track subcellular localization by immunofluorescence

• Flow cytometry correlation:

  • Fix cells and stain with SPBC354.10 antibody

  • Counterstain with propidium iodide for DNA content

  • Analyze correlation between SPBC354.10 signal and cell cycle position

• Co-localization with cell cycle markers:

  • Perform double immunofluorescence with SPBC354.10 antibody and:

    • Anti-Cdc13 (cyclin B) for G2/M transition

    • Anti-Sad1 for spindle pole bodies

    • Anti-tubulin for mitotic spindle

  • Quantify spatial relationships through cell cycle progression

• Live cell imaging with strain expressing:

  • SPBC354.10-GFP fusion

  • Cell cycle phase markers (e.g., Sid4-mCherry)

  • Time-lapse microscopy to track dynamics

How can I use SPBC354.10 antibody to investigate responses to DNA damage and replication stress?

For studying SPBC354.10's role in genome stability:

• DNA damage response analysis:

  • Treat cells with DNA damaging agents:

    • UV irradiation

    • Methyl methanesulfonate (MMS)

    • Hydroxyurea

    • Camptothecin

  • Monitor SPBC354.10 levels, modification state, and localization

  • Compare with known DNA damage response proteins like Rad22

• Chromatin association dynamics:

  • Perform ChIP-qPCR at specific genomic loci:

    • Induced DNA breaks

    • Replication origins

    • Repetitive sequences

  • Quantify changes in SPBC354.10 recruitment following damage

  • This approach has been used effectively to study proteins like Png1p at specific loci

• Protein complex remodeling:

  • Conduct immunoprecipitation before and after DNA damage

  • Identify changes in SPBC354.10 interaction partners

  • Connect to known DNA repair pathways

• Genetic interaction studies:

  • Use SPBC354.10 antibody in strains with mutations in DNA repair genes

  • Analyze synthetic phenotypes and changes in SPBC354.10 behavior

  • Determine epistatic relationships

What approaches can I use to study post-translational modifications of SPBC354.10?

To characterize SPBC354.10 modifications:

• Specialized Western blot analysis:

  • Use Phos-tag or Mn2+-Phos-tag gels to detect phosphorylation

  • Run 2D gel electrophoresis to separate based on charge and mass

  • Use modification-specific antibodies if available

• Mass spectrometry approaches:

  • Immunoprecipitate SPBC354.10 using specific antibody

  • Digest with trypsin or other proteases

  • Analyze by LC-MS/MS with specific focus on:

    • Phosphorylation (STY residues)

    • Acetylation (K residues)

    • Methylation (K and R residues)

    • Ubiquitination (K residues)

  • Similar approaches have identified modifications on proteins like Spt5

• In vitro modification assays:

  • Express and purify recombinant SPBC354.10

  • Incubate with candidate modifying enzymes

  • Detect modifications using antibodies or mass spectrometry

• Correlation with known modification sites:

  • Compare with homologous proteins in other organisms

  • Test conservation of modification sites

  • Assess functional consequences through mutagenesis

This characterization would provide insights into the regulation of SPBC354.10 and whether it participates in processes like the Cdk9-dependent pathways that regulate other S. pombe proteins .

How should I analyze ChIP-seq data from SPBC354.10 antibody experiments?

For comprehensive ChIP-seq data analysis:

• Primary analysis pipeline:

  • Quality control of sequencing data (FastQC)

  • Align reads to S. pombe genome (Bowtie2, BWA)

  • Remove duplicates and filter for quality

  • Generate normalized coverage tracks

  • Call peaks (MACS2, HOMER) using appropriate input controls

• Binding profile characterization:

  • Annotate peaks relative to genomic features

  • Generate average profiles around transcription start sites

  • Identify enriched DNA motifs within peaks

  • Compare with published datasets of chromatin marks and transcription factors

• Integrative analysis:

  • Correlate binding with gene expression data

  • Compare with histone modification profiles

  • Analyze co-localization with known complexes

  • This approach can reveal functional relationships similar to those found between Prf1 and chromatin modifications

• Validation of key findings:

  • Confirm selected targets by ChIP-qPCR

  • Test functional relationship through genetic analysis

  • Assess direct regulation via reporter assays

This analytical approach will help determine whether SPBC354.10 has targeted genomic associations similar to characterized chromatin factors in S. pombe.

How can I distinguish between direct and indirect effects when interpreting SPBC354.10 antibody results?

To differentiate direct from indirect effects:

• Temporal analysis:

  • Perform time-course experiments after induction/repression

  • Early changes (minutes to hours) more likely represent direct effects

  • Late changes (many hours to days) often reflect indirect consequences

• Genetic approaches:

  • Create an analog-sensitive SPBC354.10 mutant for rapid inhibition

  • Use degron-tagged SPBC354.10 for controlled protein depletion

  • Compare acute vs. chronic loss phenotypes

  • These approaches have been used effectively for kinases like Cdk9

• Biochemical evidence for direct interaction:

  • In vitro binding assays with purified components

  • Crosslinking followed by mass spectrometry

  • Structural studies of complexes

• Integration of multiple data types:

  • Combine ChIP-seq, RNA-seq, and proteomics

  • Look for convergent evidence across different approaches

  • Build network models to identify direct vs. downstream effects

• Controls with catalytically inactive mutants:

  • Compare binding profiles with functional consequences

  • Separate scaffolding from enzymatic functions

These strategies help establish causality and avoid misattribution of phenotypes to direct SPBC354.10 function.

How should I interpret discrepancies between antibody-based results and genetic studies of SPBC354.10?

When antibody results conflict with genetic data:

• Potential sources of discrepancy:

  • Antibody specificity issues

  • Partial protein function retention in genetic mutants

  • Compensation mechanisms in genetic knockouts

  • Differences in experimental conditions

  • Technical artifacts in either approach

• Resolution strategies:

  • Use multiple independent antibodies targeting different epitopes

  • Compare different genetic approaches (deletion, depletion, point mutation)

  • Perform rescue experiments with wild-type and mutant proteins

  • Create tagged versions and compare antibody vs. tag detection

  • Use complementary techniques like mass spectrometry

• Specific validation approaches:

  • For localization discrepancies: Compare IF, fractionation, and live imaging

  • For interaction discrepancies: Compare IP-MS, Y2H, and in vitro binding

  • For functional discrepancies: Test genetic epistasis and biochemical activity

• Interpretation framework:

  • Consider timing differences (acute vs. chronic effects)

  • Evaluate partial vs. complete loss of function

  • Assess potential dominant-negative effects

  • This type of careful analysis has been important for understanding proteins like PAF and Prf1

Reconciling these differences often leads to deeper biological insights about protein function and regulation.

What are the key considerations for designing experiments with SPBC354.10 antibody?

When planning SPBC354.10 antibody experiments, researchers should:

• Validate antibody specificity through multiple approaches:

  • Genetic controls (deletion/depletion strains)

  • Peptide competition

  • Detection of tagged versions

• Optimize experimental conditions for each application:

  • Extraction methods appropriate for subcellular localization

  • Fixation and permeabilization protocols for immunofluorescence

  • Crosslinking and sonication parameters for ChIP

• Include comprehensive controls:

  • Positive and negative controls for specificity

  • Technical controls for normalization

  • Biological controls for interpretation

• Consider potential limitations:

  • Low expression levels requiring optimization

  • Cell cycle or condition-dependent regulation

  • Post-translational modifications affecting detection

  • Similar issues have been encountered with proteins like Rbm10 and other chromatin-associated factors

• Integrate with complementary approaches:

  • Genetic methods (deletion, mutation)

  • Tagged protein studies

  • Proteomic analyses

  • Functional assays